[artículo] 
inThe American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 122-131

Título :	Rel-1017 (esmethadone) as adjunctive treatment in patients with major depressive disorder : a phase 2a randomized double-blind trial
Tipo de documento:	texto impreso
Autores:	Maurizio Fava, Autor ; Stephen M. Stahl, Autor ; Luca Pani, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 122-131
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastornos depresivos, Trastorno depresivo mayor, Neurología
Resumen:	The purpose of this study was to examine the effects of REL-1017 (esmethadone), a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker, in patients with major depressive disorder who failed to benefit from one to three standard antidepressant treatments in their current major depressive episode.
Link:	./index.php?lvl=notice_display&id=28331

[artículo] Rel-1017 (esmethadone) as adjunctive treatment in patients with major depressive disorder : a phase 2a randomized double-blind trial [texto impreso] / Maurizio Fava, Autor ; Stephen M. Stahl, Autor ; Luca Pani, Autor . - 2022 . - pp. 122-131.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 122-131

Palabras clave:	Trastornos depresivos, Trastorno depresivo mayor, Neurología
Resumen:	The purpose of this study was to examine the effects of REL-1017 (esmethadone), a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker, in patients with major depressive disorder who failed to benefit from one to three standard antidepressant treatments in their current major depressive episode.
Link:	./index.php?lvl=notice_display&id=28331